Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting Intimation for Results & Closure of Trading Window

 Neuland Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company will be held on February 10, 2017, inter alia, to consider and take on record the Unaudited financial results of the Company for the quarter ended December 31, 2016.As per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for transactions in shares of the Company is closed from January 25,...
17-01-2017
Bigul

Shareholding for the Period Ended December 31, 2016

 Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here
04-01-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Neuland Health Sciences Pvt Ltd
29-12-2016
Bigul

Analyst / Institutional Investor Meet

 Neuland Laboratories Ltd has informed BSE regarding "Analyst / Institutional Investor Meet".
30-11-2016
Bigul

Presentation

 Neuland Laboratories Ltd has submitted to BSE a copy of a Presentation on Scheme of Amalgamation and Arrangementbetween Neuland Laboratories Limited ("NIL") and Neuland Health Sciences Private Limited ("NHSPL") and Neuland Pharma Research Private Limited ("NPRPL"), being uploaded on the Website of the Company.
08-11-2016
Bigul

Outcome of Board Meeting

 Neuland Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 04, 2016, inter alia, has accorded the following;1. Scheme of Amalgamation and Arrangement amongst the Company, Neuland Health Sciences Private Limited (NHSPL) and Neuland Pharma Research Private Limited (NPRPL) and their respective shareholders and creditors. As a part of the proposed merger, both NHSPL and NPRPL will...
04-11-2016
Bigul

Standalone Financial Results, Limited Review Report, Results Press Release for September 30, 2016

 Neuland Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 20163. Result Press Release for the period ended September 30, 2016
04-11-2016
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 Neuland Health Sciences Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
01-11-2016
Bigul

Results Release and Earnings Call Notice

 Neuland Laboratories Ltd has submitted to BSE a copy of the Q2 FY 2017 Earnings Call details.
01-11-2016
Bigul

Updates on ensuing Board Meeting on Nov 04, 2016

 With reference to the earlier letter dated October 12, 2016, Neuland Laboratories Ltd has now informed BSE that the meeting scheduled to be held on November 04, 2016, inter alia, would also consider a draft Scheme of Amalgamation and Arrangement between Neuland Laboratories Limited ("the Company"), Neuland Health Sciences Private Limited and Neuland Pharma Research Private Limited, along with the Un-audited financial results of the Company for the quarter ended September 30, 2016....
31-10-2016
Next Page
Close

Let's Open Free Demat Account